ArticleFrontiers in pharmacology2025
Implementation and impact analysis of a clinical pharmacy ambulatory: a two-year experience.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Telepharmacy-supported multidisciplinary management and clinical outcomes in patients with transthyretin amyloid cardiomyopathy treated with tafamidis: a real-world study.Clinical research in cardiology : official journal of the German Cardiac Society · 2026Article
- Beyond prescriptions: an analysis of patient journey, self-management adherence, and unmet needs in type 2 diabetes.BMC health services research · 2026Article
- Advancing interprofessional collaboration: exploring physicians' perceptions, preferences, and barriers regarding pharmacists' roles in Jordan.Journal of pharmaceutical policy and practice · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Clinical pharmacy services contribute to safer and more effective medication use, yet remain underdeveloped in several countries, including Italy, due to limited recognition and funding. Local initiatives are essential to demonstrate feasibility and impact. Objective: To describe the 2-year implementation of a Clinical Pharmacy Ambulatory (CPA) in a large Italian tertiary hospital, and to evaluate its contribution to medication management, adherence, and interprofessional collaboration. Methods: The CPA was established within the Hospital Pharmacy Department of the Azienda Ospedale-Università di Padova. It provided three pharmacist-led services: best possible medication history (BPMH), medication review (MR), and patient education programs (PEPs). Services were delivered on-site and through telepharmacy, integrated into the electronic medical record. Outcomes were assessed using key performance indicators, including service volumes, fulfillment rates, acceptance of recommendations, and adherence measures. A survey of healthcare professionals assessed changes in perception of pharmacists' role. Results: Over 2 years, the CPA served more than 2,200 patients. BPMH activity increased by 12%, with fulfillment consistently above 97%. Fifty-one medication reviews generated 670 therapeutic recommendations, with high physician acceptance (over 70%). PEPs enrolled 151 patients, achieving excellent adherence outcomes. Surveys showed improved awareness of the pharmacist's role and stronger support for their integration into multidisciplinary care. Conclusion: The CPA represents the first structured pharmacist-led ambulatory formally described in Italy. It demonstrates feasibility, clinical relevance, and organizational value in a healthcare system where clinical pharmacy is not yet institutionalized. This model may inform broader adoption of pharmacist-led services in countries where clinical pharmacy remains underdeveloped.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.